Trial intelligence / Profile preview

TREAT: Ticagrelor vs Clopidogrel in STEMI Post-Thrombolysis

NCT02298088Phase 3Completed

Sponsor
HCor
Start
Aug 2015
Primary completion
Dec 2017
Modality
Small Molecules
Countries
10
01

Overview

A Phase 3 trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by HCor. Started Aug 2015; status: completed.

02

Drugs

ticagrelor
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02298088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02298088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call